17 May 2019 1 Min Read
Aspen shares rise after sale of nutritionals business gets nod
Drugmaker Aspen Pharmacare says the sale to Lactalis has been approved by regulators in New Zealand
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In